PUBLISHER: Allied Market Research | PRODUCT CODE: 1097627
PUBLISHER: Allied Market Research | PRODUCT CODE: 1097627
The global cardiac surgical devices market was valued at $2,208.73 million in 2020 and is projected to reach $3052.38 million by 2030, registering a CAGR of 3.3% from 2021 to 2030.
Cardiac surgery is the process performed to cure heart tissue defects, such as replacing the diseased heart valves (if blocked), grafting, or replacement of heart tissues in case of damage. There are two major types of heart surgeries performed-closed and open. Cardiac surgical devices are used for angioplasty, valve replacements, stent placement, and open heart surgery.
Factors that drive the growth of cardiac surgical devices market are increase in health and lifestyle disorders, rise in the prevalence of cardiovascular diseases, surge in the geriatric population with rising co-morbidities, increase in sedentary lifestyles, rise in excessive cigarette use, surge in number of diabetic patients, and increase in the number of people suffering from obesity. Increase in number of people suffering from vascular malfunctions and congenital defects as well as rise in the number of people suffering from poor nutrition as a result of changing lifestyles and an increase in the obese population, are expected to drive the growth of cardiovascular surgical devices market. However, in the developing and undeveloped countries, there are economic limits associated with these devices, as well as lack of experienced personnel.
The global cardiac surgical devices market is segmented on the basis of product, application, and age group. Based on product type, it is fragmented into beating heart surgery systems, cardiopulmonary bypass equipment, cardiac ablation devices, and perfusion disposable. Depending on application, it is categorized into congenital heart defects, cardiac arrhythmia, coronary heart disease, and congestive heart failure. On the basis of age group, it is categorized into, new-born, infant, children, and adults. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key market players profiled in the report include: includes Edwards Life Science Corporation, Medtronic Inc., Getinge Group, Atrion Corporation, Abbott Laboratories, Sorin S.P.A., Terumo Medical Corporation, Boston Scientific Corporation, Cook Medical, and Angiodynamics, Inc.
By Product Type
By Application
By Age Group
By Region